Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CEL | P19835 | 2/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.30 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.30 |
| ▸ | KMO | O15229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1776322 | 0.98 | CEL (0.33) | CELHDAC4HDAC2HDAC8CASP3 | |
| SCHEMBL455221 | 0.91 | — | — | |
| SCHEMBL21777712 | 0.84 | CEL (0.36) | CELHDAC4HDAC2HDAC8CASP3 | |
| SCHEMBL1777152 | 0.82 | CEL (0.38) | CELHDAC4HDAC2HDAC8CASP3 | |
| SCHEMBL17710524 | 0.80 | CEL (0.32) | CELHDAC4HDAC2HDAC8KMO | |
| SCHEMBL1778508 | 0.75 | CEL (0.32) | CELKMO | |
| SCHEMBL1776833 | 0.75 | PTPN1 (0.34) | CELKMO | |
| SCHEMBL16752251 | 0.74 | AKR1C3 (0.31) | — | |
| SCHEMBL1777508 | 0.73 | HTR1A (0.31) | CELKMO | |
| SCHEMBL1776893 | 0.71 | EPHX2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080306310-A1 | AVOIDANCE OF SOLIDS DEPOSITS IN DROPLET SEPARATORS BY METERING IN SUITABLE LIQUIDS | BAYER MATERIALSCIENCE AG (DE) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306310-A1 | AVOIDANCE OF SOLIDS DEPOSITS IN DROPLET SEPARATORS BY METERING IN SUITABLE LIQUIDS | HMGCR, LIPA, SCD | CEL 40/4885HDAC4 3093/4885HDAC2 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.